Literature DB >> 8027

Paragangliomatosis associated with multiple endocrine adenomas.

F Farhi, S H Dikman, W Lawson, R H Cobin, F G Zak.   

Abstract

A 19-year-old woman had multiple functioning extra-adrenal paragangliomas, a pituitary adenoma associated with acromegaly, parathyroid hyperplasia, and pigmentary abnormalities. This case differs from previously described instances of multiple endocrine adenomatosis (MEA) and has features that bridge the classic MEA type 1 and 2 syndromes and possibly Von Recklinghausen disease. The coexistence of pheochromocytoma with acromegaly is extremely rare, and the association with extra-adrenal paragangiliomas appears to be unique. Thyroid parafollicular cell proliferation could not be proved by immunohistochemical or electron microscopical studies. The large number and extensive distribution of paragangliomas, ranging from neck to pelvis, is another unique feature of this case. The concept of neurocrestopathy or of an endocrine polypeptide (APUD) cell system may offer an explanation for the interrelation of these diverse growths.

Entities:  

Mesh:

Year:  1976        PMID: 8027

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  8 in total

Review 1.  Multiple endocrine neoplasia type I: general features and new insights into etiology.

Authors:  M L Brandi
Journal:  J Endocrinol Invest       Date:  1991-01       Impact factor: 4.256

2.  Serum gastrin, calcitonin, and prolactin as markers of multiple endocrine neoplasia syndromes in patients with primary hyperparathyroidism.

Authors:  J R Farndon; J M Geraghty; W G Dilley; S Handwerger; G S Leight
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

Review 3.  The 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors.

Authors:  Paraskevi Xekouki; Ana Brennand; Ben Whitelaw; Karel Pacak; Constantine A Stratakis
Journal:  Horm Metab Res       Date:  2018-10-01       Impact factor: 2.936

4.  Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and/or Krebs cycle defects?

Authors:  Paraskevi Xekouki; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2012-10-30       Impact factor: 5.678

Review 5.  Coexistence of a pituitary macroadenoma and pheochromocytoma--a case report and review of the literature.

Authors:  Suzanne M Breckenridge; Amir H Hamrahian; Charles Faiman; John Suh; Richard Prayson; Marc Mayberg
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

6.  Acromegaly secondary to growth hormone-releasing hormone secreted by an incidentally discovered pheochromocytoma.

Authors:  L Vieira Neto; G F Taboada; L L Corrêa; J Polo; A F Nascimento; L Chimelli; K Rumilla; M R Gadelha
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

7.  18F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma.

Authors:  Aisha A Tepede; James Welch; Maya Lee; Adel Mandl; Sunita K Agarwal; Naris Nilubol; Dhaval Patel; Craig Cochran; William F Simonds; Lee S Weinstein; Abhishek Jha; Corina Millo; Karel Pacak; Jenny E Blau
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-03-03

Review 8.  An update on adrenal endocrinology: significant discoveries in the last 10 years and where the field is heading in the next decade.

Authors:  Crystal D C Kamilaris; Constantine A Stratakis
Journal:  Hormones (Athens)       Date:  2018-11-19       Impact factor: 2.885

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.